Parkinson’s Disease Debate
Full Debate: Read Full DebateRebecca Smith
Main Page: Rebecca Smith (Conservative - South West Devon)Department Debates - View all Rebecca Smith's debates with the Foreign, Commonwealth & Development Office
(1 day, 11 hours ago)
Westminster HallWestminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.
Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
Gregory Stafford (Farnham and Bordon) (Con)
I congratulate the hon. Member for Colne Valley (Paul Davies) on introducing this debate.
Every hour, two more people in the United Kingdom hear the life-changing words, “You have Parkinson’s.” As I have said before, for me, this is personal. A close family member was first diagnosed with Parkinson’s and later with progressive supranuclear palsy, a more aggressive condition, but my family’s experience is far from unique. Numerous constituents have contacted me about this debate—including Ellie from Farnham, who is in the Public Gallery today—and they all speak plainly about their daily reality, including mobility issues, speech challenges and the emotional strain that falls on individuals and their families. Their stories show extraordinary resilience, but also the gaps in support that remain.
Rebecca Smith (South West Devon) (Con)
Does my hon. Friend agree that the current pathway for innovative technology to be licensed is both costly and time consuming, meaning inventions that would help his constituents, such as BeechBand, which uses vibrotactile stimulation to decrease symptoms, face delays in testing and potential introduction, and that we need to find a way forward?
Gregory Stafford
I have also been approached by BeechBand. I hope the Minister agrees that the Medicines and Healthcare products Regulatory Agency and the Government must ensure that where there are new, innovative technologies that could help sufferers of Parkinson’s or any other disease condition, they can get to the frontline to help people as quickly as possible.